JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Liabilities | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr | ₹104 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2024 | ₹164 Cr |
Mar2023 | ₹141 Cr |
Mar2022 | ₹143 Cr |
Mar2021 | ₹120 Cr |
Mar2020 | ₹104 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹164 Cr | 16.21 | |
Mar2023 | ₹141 Cr | -0.84 | |
Mar2022 | ₹143 Cr | 18.38 | |
Mar2021 | ₹120 Cr | 15.38 | |
Mar2020 | ₹104 Cr | - |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹423.5 Cr | -3.7% | -17.2% | 27.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,246.0 Cr | 4.7% | -5.4% | 0.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹147,119.0 Cr | 0.5% | -9.8% | 55.5% | Stock Analytics | |
CIPLA | ₹116,805.0 Cr | 2% | -1.8% | -1.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹103,554.0 Cr | 2.6% | -6.1% | 14% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹93,192.0 Cr | -0.9% | -10% | -11.3% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -3.7% |
-17.2% |
27.1% |
SENSEX | 1.5% |
-5.1% |
0.6% |
You may also like the below Video Courses